Other expense (income), net for the three and nine months ended September 30, 2026 and 2025 consists of: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three Months Ended September 30, | | Nine Months Ended September 30, | | (in millions) | | 2026 | | 2025 | | 2026 | | 2025 | | Asset impairments | | $ | 4 | | | $ | — | | | $ | 13 | | | $ | — | | | Restructuring, integration and separation costs | | 9 | | | 11 | | | 21 | | | 43 | | | Gain on sale of assets | | — | | | (6) | | | (3) | | | (6) | | | Litigation and other matters | | 8 | | | 1 | | | 20 | | | 8 | | | Acquired in-process research and development costs | | — | | | — | | | 16 | | | 29 | | | Acquisition-related costs | | 3 | | | 2 | | | 4 | | | 5 | | | Acquisition-related contingent consideration | | 6 | | | (23) | | | 10 | | | (50) | | | | | | | | | | | Other expense (income), net | | $ | 30 | | | $ | (15) | | | $ | 81 | | | $ | 29 | |
|